id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-345358-b9u1l3sz	Jacobs, Jeffrey	Case Report of a SARS-CoV-2 Infection in a Patient With Ulcerative Colitis on Tofacitinib	2020-04-28		.txt	text/plain	736	48	55	title: Case Report of a SARS-CoV-2 Infection in a Patient With Ulcerative Colitis on Tofacitinib The emergence of a novel coronavirus in December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its resultant disease, COVID-19, has led to a global pandemic with severe disease in 14% of those infected and a case fatality rate of 2.3% reported in China. Furthermore, in IBD patients with COVID-19, the best management strategy has yet to be determined with regard to immunosuppressive medications, many of which have a long serum half-life and even longer tissue effect that can persist much longer than the course of a typical infection. 2, 3 The case presented here illustrates that in a relatively healthy individual, tofacitinib may not need to be held in patients with COVID-19 without severe disease.	./cache/cord-345358-b9u1l3sz.txt	./txt/cord-345358-b9u1l3sz.txt